A note on what follows: we are writers and editors reading the research, not clinicians or psychologists. These are patterns ...

How the Grosvenor family used a 300-year-old leasehold trick to keep the ground beneath London's most expensive addresses — ...

In the hyperarid core of Chile's Atacama Desert, weather stations have gone decades without recording a single drop of rain — ...

The most important AI chart for startups may not be the one showing larger models, higher benchmark scores or billion-dollar training runs. It may be the one ...

Carl Jung split a human life down the middle and gave each half a different job. The first half, he said, is spent building ...

The daily step goal on hundreds of millions of wrists and phones did not come out of a laboratory. It came out of a marketing ...

We tend to treat being good at AI as a technical skill, something to do with clever prompts, the right settings and a stock ...

I did not get calmer by reading grand books about attention or by taking a week-long digital detox in the woods. I got calmer by doing five small, mildly ...

Every so often you get to a point where the same three or four questions have been circling for months and none of them are getting answered. The kind of ...

Roughly one in eight American adults is now taking a GLP-1 drug like Ozempic, Wegovy or Zepbound. The class traces back to a hormone isolated from Gila monster venom by a Bronx doctor who paid a ...

Ozempic lists for roughly $969 in the United States and around €59 in Germany — the same pen, the same molecule, made in the same Danish factory. The reason winds back to a Nobel laureate's 1922 trip ...

The Munich drone maker calls itself a "neo prime" that says it can upend the defense establishment. The establishment just helped write the check — and says its own role is changing.